Table I.

Application for selected biomarkers (adapted: Lewis JD. The utility in the diagnosis and therapy of inflammatory bowel disease. Gastroenterology 2011; 140: 1817-26)

	FCP	Lactoferrin	S100A12	CRP	Serologies
IBD vs. other disease	+	+	+	+	+
UC vs. CD					+
Risk of complications					+
Active disease vs. remission	+	+	+	+
Assess mucosal healing	+	+	+	+
Predict relapse	+	+	+	+
Predict response to therapy	+	+	+	+	+

Note: The table includes both confirmed and theoretical roles for these biomarkers